Institutional Manager · CIK 0001839948
TCG Crossover Management, LLC
PALO ALTO, CA · File #028-22283
Latest AUM
$3.02B
Positions
43
Top-10 Concentration
64.3%
Filings
12
Sector Allocation
Filing History
View all filings →- 13F HOLDINGS REPORTQ/E Dec 202543 pos · $3.02B
- 13F HOLDINGS REPORTQ/E Sep 202540 pos · $2.03B
- 13F HOLDINGS REPORTQ/E Jun 202538 pos · $875.5M
- 13F HOLDINGS REPORTQ/E Mar 202538 pos · $733.1M
- 13F HOLDINGS REPORTQ/E Dec 202438 pos · $1.02B
- 13F HOLDINGS REPORTQ/E Sep 202436 pos · $1.18B
- 13F HOLDINGS REPORTQ/E Jun 202432 pos · $959.5M
- 13F HOLDINGS REPORTQ/E Mar 202433 pos · $1.26B
- 13F HOLDINGS REPORTQ/E Dec 202326 pos · $679.1M
- 13F HOLDINGS REPORTQ/E Sep 202322 pos · $609.8M
- 13F HOLDINGS REPORTQ/E Jun 202322 pos · $513.0M
- 13F HOLDINGS REPORTQ/E Mar 202321 pos · $566.6M
Top 20 Holdings — Dec 2025
| # | Issuer | Ticker | Shares | Value | % of Portfolio |
|---|---|---|---|---|---|
| 1 | ABIVAX SA AMERICAN DEPOSITARY SHARES | AAVXF | 7,111,596 | $959.0M | 31.74% |
| 2 | COGENT BIOSCIENCES INC | COGT | 5,868,162 | $208.4M | 6.90% |
| 3 | CG ONCOLOGY INC | CGON | 3,670,206 | $152.4M | 5.04% |
| 4 | TANGO THERAPEUTICS INC | TNGX | 12,762,094 | $113.1M | 3.74% |
| 5 | CENTESSA PHARMACEUTICALS PLC | CNTA | 4,286,480 | $107.2M | 3.55% |
| 6 | DYNE THERAPEUTICS INC | DYN | 4,615,144 | $90.3M | 2.99% |
| 7 | RAPT THERAPEUTICS INC | 75382E208 | 2,582,408 | $87.5M | 2.89% |
| 8 | TYRA BIOSCIENCES INC | TYRA | 2,898,103 | $76.2M | 2.52% |
| 9 | AMYLYX PHARMACEUTICALS INC | AMLX | 6,243,812 | $75.4M | 2.50% |
| 10 | SAVARA INC | SVRA | 12,362,205 | $74.5M | 2.47% |
| 11 | MONTE ROSA THERAPEUTICS INC | GLUE | 4,622,151 | $72.5M | 2.40% |
| 12 | OCULAR THERAPEUTIX INC | OCUL | 5,740,231 | $69.7M | 2.31% |
| 13 | DIANTHUS THERAPEUTICS INC | DNTH | 1,676,624 | $69.1M | 2.29% |
| 14 | EYEPOINT PHARMACEUTICALS INC | EYPT | 3,572,335 | $65.3M | 2.16% |
| 15 | STRUCTURE THERAPEUTICS INC | GPCR | 920,857 | $64.0M | 2.12% |
| 16 | SPYRE THERAPEUTICS INC | SYRE | 1,900,582 | $62.3M | 2.06% |
| 17 | FULCRUM THERAPEUTICS INC | FULC | 5,250,000 | $59.4M | 1.97% |
| 18 | LIQUIDIA TECHNOLOGIES INC | LQDA | 1,710,084 | $59.0M | 1.95% |
| 19 | BIOHAVEN LTD | BHVN | 4,631,317 | $52.3M | 1.73% |
| 20 | IMMUNOVANT INC | IMVT | 1,660,933 | $42.2M | 1.40% |